Rıdvan Ali
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Platelet Disorders and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 24
- Chronic Myeloid Leukemia Treatments 11
- Acute Myeloid Leukemia Research 5
- Genetics 19
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Chronic Lymphocytic Leukemia Research 8
- Co-authors
- Fahir Özkalemkaş (32 shared papers)Vildan Özkocaman (30 shared papers)Ahmet Tunalı (14 shared papers)Yalçın Kímya (6 shared papers)Tülay Özçelik (15 shared papers)Nilgün Köksal (3 shared papers)Tahsin Yakut (8 shared papers)Ülkü Özan (3 shared papers)
- Journals
- Leukemia Research (3 papers)Annals of Hematology (3 papers)Scientific Reports (2 papers)Annals of Clinical Microbiology and Antimicrobials (2 papers)European Journal Of Haematology (2 papers)
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
Rıdvan Ali
49 papers receiving 590 citations
Peers
Comparison fields: 5 of 67
- Hematology 348
- Genetics 130
- Oncology 216
- Rheumatology 104
- Public Health, Environmental and Occupational Health 129
Countries citing papers authored by Rıdvan Ali
This map shows the geographic impact of Rıdvan Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rıdvan Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rıdvan Ali more than expected).
Fields of papers citing papers by Rıdvan Ali
This network shows the impact of papers produced by Rıdvan Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rıdvan Ali. The network helps show where Rıdvan Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Rıdvan Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 103 | |
| 2 | 2008 | 53 | |
| 3 | 2004 | 45 | |
| 4 | 2005 | 41 | |
| 5 | 2003 | 31 | |
| 6 | 2013 | 23 | |
| 7 | 2009 | 21 | |
| 8 | 2003 | 18 | |
| 9 | 2003 | 17 | |
| 10 | 2012 | 15 | |
| 11 | 2006 | 14 | |
| 12 | 2004 | 14 | |
| 13 | 2016 | 13 | |
| 14 | 2012 | 13 | |
| 15 | 2018 | 13 | |
| 16 | 2010 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2010 | 11 | |
| 19 | 2015 | 11 | |
| 20 | 2006 | 11 |
About Rıdvan Ali
Rıdvan Ali is a scholar working on Hematology, Genetics, Oncology, Rheumatology and Molecular Biology, having authored 55 papers that have together received 609 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Eosinophilic Disorders and Syndromes (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers), Acute Myeloid Leukemia Research (5 papers) and Cancer Risks and Factors (5 papers). The work is most often cited by research in Hematology (348 citations), Genetics (130 citations), Oncology (216 citations), Rheumatology (104 citations) and Public Health, Environmental and Occupational Health (129 citations). Rıdvan Ali has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Fahir Özkalemkaş, Vildan Özkocaman, Ahmet Tunalı, Yalçın Kímya, Tülay Özçelik, Nilgün Köksal, Tahsin Yakut, Ülkü Özan, Meral Beksaç and Hakan Özdoğu. Their work appears in journals such as Leukemia Research, Annals of Hematology, Scientific Reports, Annals of Clinical Microbiology and Antimicrobials and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.